314 related articles for article (PubMed ID: 12719860)
1. [Antipruritic effects of pimecrolimus and tacrolimus].
Ständer S; Luger TA
Hautarzt; 2003 May; 54(5):413-7. PubMed ID: 12719860
[TBL] [Abstract][Full Text] [Related]
2. Topical pimecrolimus and tacrolimus transiently induce neuropeptide release and mast cell degranulation in murine skin.
Ständer S; Ständer H; Seeliger S; Luger TA; Steinhoff M
Br J Dermatol; 2007 May; 156(5):1020-6. PubMed ID: 17388925
[TBL] [Abstract][Full Text] [Related]
3. [Antipruritic mechanisms of pimecrolimus cream for facial dermatitis in adult women patients].
Xie ZQ; Yang GY; Jiang W; Xu ML
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Feb; 31(1):27-30. PubMed ID: 19317053
[TBL] [Abstract][Full Text] [Related]
4. Analgesic and antipruritic effects of oxymatrine sustained-release microgel cream in a mouse model of inflammatory itch and pain.
Zhu T; Zhou D; Zhang Z; Long L; Liu Y; Fan Q; Chen F; Zhang X; Wu Y; Zeng H; Verkhratsky A; Zhao J; Nie H
Eur J Pharm Sci; 2020 Jan; 141():105110. PubMed ID: 31654757
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the antipruritic effects of topical pimecrolimus in non-atopic prurigo nodularis: results of a randomized, hydrocortisone-controlled, double-blind phase II trial.
Siepmann D; Lotts T; Blome C; Braeutigam M; Phan NQ; Butterfass-Bahloul T; Augustin M; Luger TA; Ständer S
Dermatology; 2013; 227(4):353-60. PubMed ID: 24281309
[TBL] [Abstract][Full Text] [Related]
6. The role of topical calcineurin inhibitors for skin diseases other than atopic dermatitis.
Wollina U
Am J Clin Dermatol; 2007; 8(3):157-73. PubMed ID: 17492844
[TBL] [Abstract][Full Text] [Related]
7. Treatment of pruritic diseases with topical calcineurin inhibitors.
Ständer S; Schürmeyer-Horst F; Luger TA; Weisshaar E
Ther Clin Risk Manag; 2006 Jun; 2(2):213-8. PubMed ID: 18360595
[TBL] [Abstract][Full Text] [Related]
8. Oral tacrolimus treatment of pruritus in prurigo nodularis.
Halvorsen JA; Aasebø W
Acta Derm Venereol; 2015 Sep; 95(7):866-7. PubMed ID: 25804254
[No Abstract] [Full Text] [Related]
9. Off-label Uses of Topical Pimecrolimus.
Ladda M; Sandhu V; Ighani A; Yeung J
J Cutan Med Surg; 2019; 23(4):442-448. PubMed ID: 31053034
[TBL] [Abstract][Full Text] [Related]
10. Update of calcineurin inhibitors to treat inverse psoriasis: A systematic review.
Dattola A; Silvestri M; Bennardo L; Del Duca E; Longo C; Bianchi L; Nisticò S
Dermatol Ther; 2018 Nov; 31(6):e12728. PubMed ID: 30295379
[TBL] [Abstract][Full Text] [Related]
11. Topical calcineurin inhibitors for the treatment of vulvar dermatoses.
Goldstein AT; Thaçi D; Luger T
Eur J Obstet Gynecol Reprod Biol; 2009 Sep; 146(1):22-9. PubMed ID: 19631446
[TBL] [Abstract][Full Text] [Related]
12. [The treatment of atopic dermatitis in adults with topical calcineurin inhibitors].
Meurer M; Wozel G
Hautarzt; 2003 May; 54(5):424-31. PubMed ID: 12719862
[TBL] [Abstract][Full Text] [Related]
13. Pimecrolimus (Elidel, SDZ ASM 981)--preclinical pharmacologic profile and skin selectivity.
Stuetz A; Grassberger M; Meingassner JG
Semin Cutan Med Surg; 2001 Dec; 20(4):233-41. PubMed ID: 11770910
[TBL] [Abstract][Full Text] [Related]
14. Mechanistic insights into topical tacrolimus for the treatment of atopic dermatitis.
Nakahara T; Morimoto H; Murakami N; Furue M
Pediatr Allergy Immunol; 2018 May; 29(3):233-238. PubMed ID: 29205511
[TBL] [Abstract][Full Text] [Related]
15. [Development and pre-clinical aspects of pimecrolimus].
Stütz A; Grassberger M; Meingassner JG
Hautarzt; 2003 May; 54(5):405-12. PubMed ID: 12719859
[TBL] [Abstract][Full Text] [Related]
16. Pimecrolimus in dermatology: atopic dermatitis and beyond.
Gisondi P; Ellis CN; Girolomoni G
Int J Clin Pract; 2005 Aug; 59(8):969-74. PubMed ID: 16033622
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of scratching behavior associated with allergic dermatitis in mice by tacrolimus, but not by dexamethasone.
Inagaki N; Shiraishi N; Igeta K; Itoh T; Chikumoto T; Nagao M; Kim JF; Nagai H
Eur J Pharmacol; 2006 Sep; 546(1-3):189-96. PubMed ID: 16914137
[TBL] [Abstract][Full Text] [Related]
18. The role of topical calcineurin inhibitors in atopic dermatitis.
Alomar A; Berth-Jones J; Bos JD; Giannetti A; Reitamo S; Ruzicka T; Stalder JF; Thestrup-Pedersen K;
Br J Dermatol; 2004 Dec; 151 Suppl 70 Dec 2004():3-27. PubMed ID: 15548171
[TBL] [Abstract][Full Text] [Related]
19. Improvement in pruritus in children with atopic dermatitis using pimecrolimus cream 1%.
Fowler J; Johnson A; Chen M; Abrams K
Cutis; 2007 Jan; 79(1):65-72. PubMed ID: 17330625
[TBL] [Abstract][Full Text] [Related]
20. Immunomodulation and safety of topical calcineurin inhibitors for the treatment of atopic dermatitis.
Hultsch T; Kapp A; Spergel J
Dermatology; 2005; 211(2):174-87. PubMed ID: 16088174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
